Immuron (IMRN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Immuron Limited has announced a significant surge in global sales of its Travelan® product, with a record increase of 174% year-over-year, reaching AUD$4.9 million. The impressive sales performance is highlighted by a 223% rise in the Australian market and a noteworthy 74% growth in the U.S. for the financial year of 2024. Buoyed by these results, Immuron anticipates further growth through increased brand investment and distribution, especially in North America.
For further insights into IMRN stock, check out TipRanks’ Stock Analysis page.